摘要
目的探究卡维地洛联合尼可地尔在治疗冠心病心肌缺血中的应用效果与价值。方法将我院在2013年9月至2014年11月期间收治的120例确诊为冠心病心肌缺血的患者,采用随机数字表法将其分为实验组(n=60)和对照组(n=60),给予对照组患者采用服卡维地洛治疗;实验组患儿采用卡维地洛联合尼可地尔治疗,对两组患者临床治疗所取得的效果和临床指标的变化情况进行观察和统计。结果实验组患者的整体治疗效果要明显的优于对照组,实验组患者治疗的总有效为98.33%;对照组患者治疗的总有效率为91.67%,两组之间的差异显著(P<0.05)。结论采用卡维地洛联合尼可地尔治疗冠心病心肌缺血的临床效果十分理想,有效的提高了治疗效果,减轻了患者的疼痛,提高了患者的生活质量,值得推广。
Objective To investigate the clinical efficacy and value of carvedilol combined with nicorandil in coronary heart disease（CHD） patients with myocardial ischemia（MI）. Methods A total of 120 CHD patients with MI admitted to our hospital from September 2013 to November 2014 were randomly divided into experiment group（n=60）and control group（n=60） using the random number table. Patients in the control group were treated with carvedilol, while patients in the control group received a combination of carvedilol and nicorandil. The treatment outcome and clinical parameters were observed and analyzed statistically. Results The overall response rate of the experiment group was significantly higher than that of the control group（98.33% vs 91.67%, P〈0.05）. Conclusion For CHD patients with MI,combined carvedilol and nicorandil has favorable clinical efficacy, reduces patients＇ suffering, and improves their quality of life, which is worthy of clinical recommendation.
出处
《心血管病防治知识（学术版）》
2015年第6期35-36,共2页
Prevention and Treatment of Cardiovascular Disease
关键词
卡维地洛
尼可地尔
冠心病心肌缺血
效果观察
Carvedilol
Nicorandil
Coronary heart disease patients with myocardial ischemia
Efficacy
